Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Highly Accessed Review

Clinical review: Hemorrhagic shock

Guillermo Gutierrez1*, H David Reines2 and Marian E Wulf-Gutierrez3

Author Affiliations

1 Professor, Pulmonary and Critical Care Medicine Division, Department of Medicine, The George Washington University Medical Center, Washington, District of Columbia, USA

2 Professor, Virginia Commonwealth University and Vice-Chairman, Department of Surgery, Inova Fairfax Hospital, Falls Church, Virginia, USA

3 Associate Professor, Department of Obstetrics and Gynecology, The George Washington University, Inova Fairfax Hospital, Falls Church, Virginia, USA

For all author emails, please log on.

Critical Care 2004, 8:373-381  doi:10.1186/cc2851


See related letter, http://ccforum.com/content/8/5/396

Published: 2 April 2004

Abstract

This review addresses the pathophysiology and treatment of hemorrhagic shock – a condition produced by rapid and significant loss of intravascular volume, which may lead sequentially to hemodynamic instability, decreases in oxygen delivery, decreased tissue perfusion, cellular hypoxia, organ damage, and death. Hemorrhagic shock can be rapidly fatal. The primary goals are to stop the bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated severity of hemorrhage. It now appears that patients with moderate hypotension from bleeding may benefit by delaying massive fluid resuscitation until they reach a definitive care facility. On the other hand, the use of intravenous fluids, crystalloids or colloids, and blood products can be life saving in those patients who are in severe hemorrhagic shock. The optimal method of resuscitation has not been clearly established. A hemoglobin level of 7–8 g/dl appears to be an appropriate threshold for transfusion in critically ill patients with no evidence of tissue hypoxia. However, maintaining a higher hemoglobin level of 10 g/dl is a reasonable goal in actively bleeding patients, the elderly, or individuals who are at risk for myocardial infarction. Moreover, hemoglobin concentration should not be the only therapeutic guide in actively bleeding patients. Instead, therapy should be aimed at restoring intravascular volume and adequate hemodynamic parameters.

Keywords:
blood loss; estimated blood volume; hemorrhage; oxygen consumption; oxygen delivery; shock; transfusion